Home>Bulk Products>4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

About Us

Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

Qualifications

DUNS: 560440352

BD100237[214360-51-7]4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide*

Specific Information

Purity : 98% Specific Rotation :
NMR(H/C/F/S/P) : E.E. :
HPLC : Water Content :
Polymerization Inhibitor : Single Impurity :
Melting Point : Density :
Packaging : Solubility :
Name Note : Acetic Acid :
Beilstein : Grade :
Specific Gravity : Viscosity :
Others :

Product Details

Cat No. : BD100237 Synonyms : 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
CAS No. : 214360-51-7 MDL NO : MFCD06657806
Formule : C12H18BNO4S InChI Key : N/A
M.W : 283.15 Pubchem ID : 16414190
Boiling Point :

Safety

Signal Word : Warning Class : N/A
Precautionary Statements : P261-P305+P351+P338 UN# : N/A
Hazard Statements : H315-H319-H335 Packing Group : N/A
GHS Pictogram:

R&D Center